LVW Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
LVW Advisors's NVO Position: Q3 2026 in Review
LVW Advisors increased its Novo Nordisk (NVO) stake by 1.6% in Q3 2026, buying an estimated $6.04K and bringing the position to 8,513 shares worth $323K. The position accounts for 0.03% of the portfolio, ranked #346.
LVW Advisors first reported a position in NVO in Q3 2019 and has held it in 29 quarters since. The position peaked at $2.38M in Q2 2024. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- LVW Advisors held 8,513 shares of Novo Nordisk worth $323K as of Q3 2026.
- LVW Advisors bought 131 Novo Nordisk shares in Q3 2026, an estimated $6.04K.
- Novo Nordisk made up 0.03% of LVW Advisors's portfolio in Q3 2026, its #346 holding.
- LVW Advisors first reported a position in Novo Nordisk in Q3 2019 and has held it in 29 quarters since.
- LVW Advisors's Novo Nordisk position peaked at $2.38M in Q2 2024.
- 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on LVW Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.